Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice
Phase 4
Completed
- Conditions
- Pain
- Interventions
- Drug: lidocaine-prilocaine creamOther: gel application for the transmission of ultrasound
- Registration Number
- NCT01094015
- Lead Sponsor
- Consorci Sanitari de Terrassa
- Brief Summary
The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysteroscopy diagnostic practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 92
Inclusion Criteria
- patients that he must perform a diagnostic hysteroscopy
- acceptance to participate in the study signed informed consent
Exclusion Criteria prerandomization:
- hypersensitivity or allergy to anesthetics
- refusal of the patient
- patients under age 18 and pregnant
Exclusion Criteria postrandomization:
- dropout
- unbearable pain that involves other analgesic measures
- allergic reactions to topical anesthetics
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lidocaine-Prilocaine cream lidocaine-prilocaine cream - placebo gel application for the transmission of ultrasound -
- Primary Outcome Measures
Name Time Method pain reduction in the performance of hysteroscopy after hysteroscopy and a month later decrease in pain immediately after the completion of hysteroscopy and one month after completion of the diagnostic test by an analogue pain scale
- Secondary Outcome Measures
Name Time Method sense of discomfort experience during the procedure a month after hysteroscopy willingness to repeat the diagnostic technique
Trial Locations
- Locations (1)
Consorci Sanitari de Terrassa
🇪🇸Terrassa, Barcelona, Spain